OTC: EDTXF - Spectral Medical Inc.

Lønnsomhet i seks måneder: -3%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Spectral Medical Inc.


Om selskapet Spectral Medical Inc.

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

flere detaljer
It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

ISIN CA8475771033
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Див.доход ао 57.14
Дивиденд ао 0.12
Сайт https://spectraldx.com
Цена ао 0.467
Prisendring per dag: +3.85% (0.467)
Prisendring per uke: -2.41% (0.497)
Prisendring per måned: +15.75% (0.419)
Prisendring over 3 måneder: +38.57% (0.35)
Prisendring over seks måneder: -3% (0.5)
Prisendring per år: +54.85% (0.3132)
Prisendring over 3 år: +74.46% (0.278)
Prisendring over 5 år: -13.39% (0.56)
Prisendring over 10 år: 0% (0.485)
Prisendring siden begynnelsen av året: +37.01% (0.354)

Undervurdering

Navn Betydning Karakter
P/S 69.3 1
P/BV -6.69 0
P/E 0 0
EV/EBITDA -10.38 0
Total: 2.25

Effektivitet

Navn Betydning Karakter
ROA, % -300.56 0
ROE, % 94.64 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0.5 5
Total: 2.35

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.719 10
Total: 9.4

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -44.28 0
Lønnsomhet Ebitda, % 214.87 10
Lønnsomhet EPS, % 98.67 9
Total: 7.8

Institusjoner Volum Dele, %
Benedetti & Gucer, Inc. 22200 0.01



Veileder Stillingstittel Betaling Fødselsår
Mr. Christopher Seto CEO, CFO & Director 351.22k
Dr. John A. Kellum M.D. Chief Medical Officer 325.75k

Adresse: Canada, Toronto, 135 The West Mall - åpne i Google maps, åpne Yandex-kart
Nettsted: https://spectraldx.com